Doctors & Nurses Around The World Reject Flu Shots

Health professional cite vaccine ineffectiveness, flu shot side effects, and flu as a "non-serious" illness

Surveys published in 2009 reveal both the acceptance and resistence of health care workers willing to receive flu shot vaccinations. Hong Kong, Germany, Saudi Arabia, Switzerland, United Kingdom and Australia, currently rank from highest to lowest refusal rates. Taken as a whole the overall majorityof healthcare workers tend to resistflu shots due to potential side effects risks, ineffectiveness of the vaccine, viewing influenza as a non-serious issue.

Hong Kong - 72%

Of 2255 healthcare workers, employed in 31 Hong Kong hospitals, 72.6% rejected taking H1N1 pre pandemic flu shots in response to a WHO influenza pandemic phase 3 alert. The rejection rate was the same for this group when given a choice refuse pre-pandemic H5N1 flu vaccine, despite an escalation to a phase 5 alert. PubmedExit Site

Germany - 65%

Refusal of the influenza vaccinations bymedical personnel ata German university hospital indicate a high resistance to taking flu vaccinations, 61.2% of doctors and 72.6% of nurses refuse to take a flu shot. The main reasons for noncompliance included: low risk of infection, fear of side effects, the belief that the influenza vaccine might trigger the influenza virus infection, and scepticism about the effectiveness of the influenza vaccination. PubmedExit Site

Saudi Arabia - 66%

In a 2009 survey, 66.8% of Saudi Arabian healthcare workers report that the influenza vaccine is not safe. 62.3% report that influenza is not a serious illness. PubmedExit Site

Switzerland - 64%

In a survey who's total number of participants consisted of fifty percentpaediatricians, routine vaccine immunization was supported by only 15% and dismissed by 64%, leaving 21% undecided. PubmedExit Site

United Kingdom - 42%

Healthcare workers willing to accept influenza vaccination shotsfromUnited Kingdom, shows 42.7% of the workers rejecting a H5N1 flu shot injection.

The survey was taken 6 months after a period of media reporting of an H5N1 outbreak at a commercial United Kingdom poultry farm. The study states, "Despite campaigns to increase seasonal influenza vaccine coverage, uptake among healthcare workers is generally low; creating uncertainty whether they would participate in offered by pre-pandemic vaccine programmes." PubmedExit Site

Australia - 42%

Although 77.5% believed that flu vaccination would be of some benefit, however only 42.5% say antiviral medicationswould protect them personally against pandemic influenza. PubmedExit Site

American Public- 2009 Flu Shot Survey - 90% Say No

2009 published in the Journal of Biosecurity and BioterrorismExit Site shows a majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided. PubmedExit Site

Flu ShotVaccine Ingredients?

Source: US Federal Center for Disease ControlExit Site (PDF download 84K)

Influenza (Afluria)

Potassium Chloride, Potassium Phosphate, Sodium Phosphate, Sodium Taurodeoxychoalate.

Influenza (Fluarix)

Egg Albumin (Ovalbumin), Egg Protein, Formaldehyde or Formalin,
Gentamicin, Hydrocortisone, Octoxynol-10, á-Tocopheryl Hydrogen Succinate,
Polysorbate 80, Sodium Deoxycholate, Sodium Phosphate, Thimerosal*

Influenza (Flulaval)

Egg Albumin (Ovalbumin), Egg Protein, Formaldehyde or Formalin, Sodium
Deoxycholate, Phosphate Buffers, includes Thimerosal

Influenza (Fluvirin)

Beta-Propiolactone, Egg Protein, Neomycin, Polymyxin B, Polyoxyethylene 9-
10 Nonyl Phenol (Triton N-101, Octoxynol 9), includes Thimerosal (multidose
containers), Thimerosal* (single-dose syringes)

Influenza (Fluzone)

Egg Protein, Formaldehyde or Formalin, Gelatin, Octoxinol-9 (Triton X-100),
includes Thimerosal (multidose containers)

Influenza (FluMist) Nasal Spray

Live H1N1 Virus, Chick Kidney Cells, Egg Protein, Gentamicin Sulfate, Monosodium Glutamate, Sucrose Phosphate Glutamate Buffer

* Where "thimerosal" is marked with an asterisk (*) it indicates that the product should be considered equivalent to thimerosal-free products. This vaccine may contain trace amounts (<0.3 mcg) of mercury left after post-production thimerosal removal, but these amounts have no biological effect. JAMA 1999;282(18) and JAMA 2000;283(16)

Adapted from Grabenstein JD. ImmunoFacts: Vaccines & Immunologic Drugs. St. Louis, MO: Wolters Kluwer Health Inc.; 2009 and individual products’ package inserts.

Autism Rates Decline as Mercury-Thimersol Removed from Childhood Vaccines

Source: Association of American Physicians and Surgeons, Inc.

Mercury continues to be a concern, as it is still added to some of the most commonly-used vaccines, such as those for flu. Despite its removal from many childhood vaccines, thimerosal is still routinely added to some formulations of influenza vaccine administered to U.S. infants, as well as to several other vaccines (e.g. tetanus-diphtheria and monovalent tetanus) administered to older children and adults. In 2004, the Institute of Medicine (IOM) of the U.S. National Academy of Sciences (NAS) retreated from the stated 1999 goal of the AAP and the PHS to remove thimerosal from U.S. vaccines as soon as possible. As a result, assessing the safety of TCVs [thimerosal-containing vaccines] is a matter of significant importance.

Common Substances Found in Vaccines:

Source: Center of Disease ControlExit Site

Additives used in the production of vaccines may include:

1. Suspending fluid (e.g. sterile water, saline, or fluids containing protein);
2. Preservatives and stabilizers to help the vaccine remain unchanged (e.g. albumin, phenols, glycine them
3. Adjuvants or enhancers that help the vaccine improve its work.

Disadvantages of Vaccine Adjuvents with Animals?

Source: Overview of Adjuvents, National Agricultural LibraryExit Site

At the site of injection, Freund's Complete Adjuvant causes a chronic inflammatory response that may be severe and painful for the animal depending on the site as well as the quantity and quality of adjuvant injected. The inflammatory response may result in formation of chronic granulomas, sterile abscesses, and/or ulcerating tissue necrosis. Adjuvant-induced lesions may appear to be metastatic when excessive amounts of the emulsion are injected in a single site. Emulsion injected subcutaneously on the dorsal region of some species (rabbit, in particular) may migrate by fistulous tracts to the ventral region of the animal. Emulsion injected intramuscularly may spread along fascial planes to distant muscular sites or may travel to lung, liver or other organs, apparently by a hematogenous route. Monitoring the site of injection as an index of health of the animal may be inadequate when excessive quantities of emulsion are injected.

Flu Mist Contra Indications

Source: Federal Drug AdministrationExit Site (PDF)

Section (4.1) - Hypersensitivity Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is contraindicated in individuals with a history of hypersensitivity, especially anaphylactic reactions, to eggs, egg proteins, gentamicin, gelatin, or arginine or with life-threatening reactions to previous influenza vaccinations.

Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is indicated for the active immunization of individuals 2-49 years of age against influenza disease caused by pandemic (H1N1) 2009 virus. (1)

ADVERSE REACTIONS information is based on studies conducted with seasonal trivalent Influenza Vaccine Live, Intranasal (FluMist) manufactured by MedImmune.

Most common adverse reactions (≥ 10% in FluMist and at least 5% greater than in control) are runny nose or nasal congestion in all ages, fever >100°F in children 2-6 years of age, and sore throat in adults. (6.1)

New York Healthcare Workers Protest Forced Vaccinations




Related: